International Biotechnology 10 October 2018
Disclosure – Non-Independent Marketing Communication
This is a non-independent marketing communication commissioned by International Biotechnology. The report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on the dealing ahead of the dissemination of investment research.
To achieve long-term capital growth by investing in biotechnology and other life sciences companies.
International Biotechnology Trust
SV Health Managers LLP
Association of Investment Companies (AIC) Sector
Sector Specialist: Biotechnology & Healthcare
Dividend Distribution Frequency
Carl Harald Janson, Ailsa Craig, Kate Bingham, Marek Poszepczynski
Kepler Trust Intelligence provides research and information for professional and private investors. In order to ensure that we provide you with the right kind of content, and to ensure that the content we provide is compliant, you need to tell us what type of investor you are.Read the full article